Flynn Daniel Lee 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Feb 18, 2022
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-02-16$9.05/sh−1,366$12,362→ 47,866 total
Holdings
- 230,435(indirect: By Trust)
Common Stock
- 91,020(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock.